Meet the Speakers
Phil Norville
Dr Phil Norville is co-founder and Chief Executive Officer of IPC Partners and has over 15 years experience working in microbiology and IPC. Phil has a Masters in IPC and a PhD in Microbiology and has undertaken a range of private and public sector roles. Phil worked as Clinical and Scientific Director for one of the world's leading IPC companies as well as IPC lead and manager for one of the UK’s largest NHS University Teaching Hospitals.
Phil combines a deep technical understanding of healthcare with commercial acumen ensuring profitability and commercial impact are at forefront of conversations with healthcare professionals and customers. Phil has a proven track record of collaboration with healthcare professionals, academic institutions and industry partners.
Trupti Patel
Trupti Patel has been a Consultant in Infectious Diseases and Microbiology for nine years and has been based at University College London Hospital for the past five years. She is also a Consultant Microbiologist at UKHSA, mainly supporting the Infection Control team.
In her NHS role, she is infection control doctor for UCLH as well for numerous community sites for the North London Foundation Trust and Central and North West London NHS Foundation Trust.
Her main interest is the role of the built environment, in particular water, in healthcare associated infections and methods of prevention.
Manjula Meda
Dr Manjula Meda is a consultant in Clinical Microbiology and the Infection Control Doctor for Frimley.
Health NHS Foundation Trust a 18800 bed hospital in Surrey. She completed her Microbiology Specialist registrar training from St. George's Hospital London rotation in 2009, following a number of years in training in Paediatrics in both the UK and in India. Since 2009 Manjula has worked in a Consultant role in microbiology and Infection prevention.
Manjula has been involved with HIS activities since 2015 serving initially as a member in its council and now as its Chair. She has represented HIS in various committees and national programmes. She is also involved actively in research in IPC and works as a research collaborator in projects with regional University and the UKHSA and as well in supporting clinical research within Frimley Health. She has managed many large IPC incidents and outbreaks and published widely in this field. She has a special interest in infection prevention and control in the built environment and has experience in managing major incidents especially around water safety in healthcare.
Mike Weinbren
Dr Michael Weinbren is a consultant medical microbiologist and infection control practitioner and a specialist Advisor Microbiology to New Hospital Programme. He is chair of the Healthcare Infection Society working party on water. He has an interest in water and wastewater systems.
Alyson Prince
Alyson is an infection prevention and control specialist who holds key experience in developing and shaping the Built Environment. She is an experienced IPCN with capability to support both the technical aspects of building services compliance and projects from an infection control perspective. Alyson is collaborating and shaping national policy development, working currently on refreshing the Infection prevention and control aspects of Health and Social Care Act (2015) with the Department of Health and Social care alongside leading IPC specialists nationally.
She provides expert insight and knowledge to key clinical stakeholders and uses her high level of understanding to better equip healthcare facilities with expert level infection control standards. Additionally, Alyson has contributed to HTM 07-01, providing infection control input as part of the clinical waste reference group in NHS England. She has recently provided evidence based expert level input at all stages of the planning process (RIBA Stages) for decant and enabling works for Children’s Cancer Centre’s and designed remodels, refurbishments, and redesigns.
Alyson has also developed new policy/protocol standards for aspects such as water hygiene management, ventilation monitoring and commissioning, building works in the clinical setting. Further to this, she developed and delivered Healthcare Engineering evaluation-based training programme for Infection Prevention at UCLH. Alyson has participated in research in collaboration with the Bartlett school for Sustainable Construction in Infection Control Aspects of Modern Methods of Construction.
Elaine Cloutman-Green
Professor Elaine Cloutman-Green is a Consultant Clinical Scientist working within Infection Prevention and Control and as Lead Healthcare Scientist for a world renowned paediatric hospital. She holds an Honorary Professorship with UCL and was awarded the British Empire Medal as part of the New Years Honours in 2021 for services to healthcare.
She started her Clinical Scientist training in 2004 in Microbiology and, during her training, she completed an MSc in Clinical Microbiology. In 2007, after completing her training, she specialised in Infection Prevention and Control. As part of this work she has undertaken a PhD whilst on the NIHR CSO Doctoral Fellowship scheme on ‘The role of the environment in transmission of healthcare associated infection’. Her research on prevention of healthcare associated infection also includes the development and implementation of rapid typing schemes in order to identify transmission. In 2016 she was awarded an NIHR ICA Clinical Lectureship in order to continue this work.
In 2015 she successfully attained Fellowship of the Royal College of Pathologists and was appointed the first UK based International Ambassador for the Society of Healthcare Epidemiology of America. In 2016 she became a Fellow of the Higher Education Academy and was appointed as a NICE Expert Advisor in Infection Prevention and Control. She became a Consultant Clinical Scientist and Deputy Director of Infection Prevention and Control in 2021.
She is the Chair of the Environmental Network, a project she is especially passionate about as it is related to her PhD. She is a member of the Science Quality Assurance Group for the Health and Safety Executive, a member of the ACB Microbiology Professionals Committee, and Country Ambassador for the American Society of Microbiology. She also holds strategic positions as a member of the NHS England AMR Programme Board and membership of the London Clinical Senate Council, as well as sitting on a number of groups for the Healthcare Infection Society.
Joost Hopman
Professor Joost Hopman, MD, PhD, DTM&H,works as the medical director and consultant microbiologist in the Radboud University Medical Center in the Netherlands and is appointed as adjunct professor at the University of Lagos, Nigeria.
Since 2020 he chairs the Prevention Committee, that coordinates all prevention projects and programs in the Radboudumc. He acts as a consultant for Doctors without Borders (Médecins sans frontières) Amsterdam. He is an advisory board member of the Infection Control African Network (ICAN) and acted as a board member of the Dutch IPC section of the Netherlands Society of Medical Microbiology (NVMM).
During the COVID-19 pandemic he served as a member of the WHO Environment and Engineering Control Expert Advisor Panel (ECAP) for COVID-19, the WHO ad-hoc COVID-19 IPC expert group and the Federation Medical Specialists (FMS) Guideline development expert group IPC, the Netherlands. Furthermore, he acted in 2020 as chair of the COVID-19 Outbreak Management Team, University Medical Center Nijmegen, The Netherlands.
Joost was invited to work as an IPC consultant for World Health Organization (WHO) in 2014 and 2015 in the Ebola outbreak response in Geneva and Sierra Leone and this has provided him with valuable experience in international outbreaks. From 2015-2018 he was appointed as a senior extraordinary lecturer in community health at the Stellenbosch University, South Africa. He is co-author of more than 50 publications in peer-review journals (among others in NEJM, JAMA network, Lancet infectious disease, EClinicalmedicine), a textbook chapter on patient areas and environmental cleaning and he contributed to WHO, CDC and WIP guidelines.
His research interests focus on prevention and healthcare delivery. It includes the epidemiology and prevention of healthcare-associated infections, new innovative methods of improving implementation of interventions as part of patient safety programs in both high- and low- resource settings and the impact of the hospital-built environment on prevention and patient safety. In 2017-2019 he was a member of the Society for Healthcare Epidemiology of America (SHEA) conference organizing committee. In 2019 Joost served as a consultant for Dutch National Institute for Public Health and the Environment (RIVM) focusing on IPC in the Dutch Caribbean. For his work he was elected as one of the International SHEA ambassadors in 2016 and was awarded with the Radboud University medal for young potentials. In 2023 Joost was awarded as the Kelsey lecturer 2023.
Joost is strongly committed to improve the health system in both high- and low/middle-income countries